Orthofix Medical
OFIX
130 hedge funds and large institutions have $472M invested in Orthofix Medical in 2024 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 45 increasing their positions, 43 reducing their positions, and 27 closing their positions.
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
5% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 43
0.85% less ownership
Funds ownership: 95.62% → 94.77% (-0.85%)
4% less funds holding
Funds holding: 136 → 130 (-6)
9% less capital invested
Capital invested by funds: $519M → $472M (-$47.8M)
15% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 27
97% less call options, than puts
Call options by funds: $10K | Put options by funds: $296K
Top Buyers
| 1 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$8.35M |
| 2 |
NM
Newtyn Management
New York
|
+$5.43M |
| 3 |
ECM
Engine Capital Management
New York
|
+$4.57M |
| 4 |
JIC
Juniper Investment Company
New York
|
+$4.24M |
| 5 |
GCM
Glenview Capital Management
New York
|
+$3.04M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$10.1M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$5.68M |
| 3 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
-$2.73M |
| 4 |
HS
HighVista Strategies
Boston,
Massachusetts
|
-$2.44M |
| 5 |
State Street
Boston,
Massachusetts
|
-$2.18M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VCM
151
Versant Capital Management
Phoenix,
Arizona
| – | -$9.86K | -679 | Closed |
|
152
First Manhattan
New York
| – | -$4.36K | -300 | Closed |
|
|
SWM
153
Spire Wealth Management
Mclean,
Virginia
| – | -$2.79K | -192 | Closed |
|
154
Group One Trading
Chicago,
Illinois
| – | -$1.8K | -124 | Closed |
|
|
S
155
SignatureFD
Atlanta,
Georgia
| – | -$624 | -43 | Closed |
|
|
AWM
156
Avior Wealth Management
Omaha,
Nebraska
| – | -$101 | -7 | Closed |
|
OFIX Hedge Fund Activity: Q2 2024 in Review
130 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q2 2024, worth a combined $472M — down 9.2% from $519M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of OFIX and 23 opened new positions — a net loss of 4 holders — while 43 trimmed existing stakes and 45 added.
The largest buyer was Paradigm Capital Management Inc, adding an estimated $8.35M. The largest seller was Morgan Stanley, cutting an estimated $10.1M.
- 130 institutional investors held Orthofix Medical (OFIX) as of Q2 2024, down from 136 in Q1 2024.
- Funds reported $472M of Orthofix Medical stock for Q2 2024, down 9.2% quarter-over-quarter.
- 23 funds opened new Orthofix Medical positions in Q2 2024 and 27 closed out, a net change of -4 holders.
- The largest Orthofix Medical buyer in Q2 2024 was Paradigm Capital Management Inc, an estimated $8.35M added.
- The largest Orthofix Medical seller in Q2 2024 was Morgan Stanley, an estimated $10.1M sold.
Based on aggregated 13F filings for Q2 2024.